Key points from article :
University College London and University College London Hospitals NHS Foundation Trust researchers scientists conducted the first-ever trial of a regenerative drug (LY3056480) to restore hearing loss.
The trial involved injecting the drug into the ears of adults with mild to moderate hearing loss.
While overall hearing wasn't restored, 45% of participants showed improvement in specific tests, suggesting the drug might partially work.
Researchers need to refine the drug and patient selection based on learnings from this initial trial.
This trial is a significant step as traditionally, hearing loss is irreversible and only managed with hearing aids.
The research team is optimistic about future advancements in regenerative therapies for hearing loss.
The results of the study were published in Nature Communications
